ArticleJournal of chemical theory and computation2026
Enabling Biomolecular Simulations with Neural Network Potentials in GROMACS.
Article in Journal of chemical theory and computation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-throughput physics-based enzyme engineering.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neural network potentials (NNPs) are rapidly changing the landscape of state-of-the-art molecular dynamics (MD) simulations. To make full use of this development, the community needs flexible, easy-to-use interfaces firmly integrated with existing methodologies. To address this, we present an interface for hybrid machine learning/molecular mechanics (ML/MM) simulations implemented in the widely used MD code GROMACS. The interface enables NNPs trained in the PyTorch framework to contribute energies and forces during MD simulations, either for selected subsets or entire molecular systems. By defining a flexible set of model inputs and outputs, the interface is agnostic to specific NNP architectures and can accommodate a wide range of descriptor-based and message-passing models. In particular, the design integrates NNP inference seamlessly into the extensive GROMACS molecular simulation ecosystem, providing users with the capability to straightforwardly combine NNPs with existing advanced sampling and free energy workflows. We demonstrate the capabilities of the interface using several representative applications, including enhanced sampling of peptide torsional free energy landscapes, absolute solvation free energy calculations, and protein-ligand simulations. We also run performance benchmarks on water boxes for several different NNP architectures. Our interface is available in recent GROMACS releases, and we believe it will provide a practical foundation for incorporating machine learning potentials into production MD simulations of biomolecular systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.